Insulin Detemir Reduces Hypoglycemic Risk at Comparable HbAfc Values Compared to NPH Insulin in Patients with Type 1 Diabetes

被引：0

|

作者：

Hermansen, Kjeld

Heller, Simon

Andersen, Marc

Russell-Jones, David L.

机构：

来源：

DIABETES | 2009年 / 58卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：A529 / A530

页数：2

相关论文

共 50 条

[1] Insulin detemir reduces hypoglycemic risk at comparable HbA1c values compared to NPH in patients with type 1 diabetes
Heller, S
Kim, H
DIABETES, 2005, 54 : A120 - A120
[2] Lower rate of hypoglycaemia but comparable glycaemic control with insulin detemir compared to NPH insulin in patients with type 1 diabetes
Hermansen, K.
Heller, S.
Andersen, M.
Russell-Jones, D. L.
DIABETOLOGIA, 2009, 52 : S359 - S359
[3] Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes
Robertson, K. J.
Schoenle, E.
Gucev, Z.
Mordhorst, L.
Gall, M. -A.
Ludvigsson, J.
DIABETIC MEDICINE, 2007, 24 (01) : 27 - 34
[4] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with Type 1 diabetes
Kolendorf, K
Prasek, M
Santeusanio, F
Philotheou, A
Gall, MA
Heller, S
DIABETOLOGIA, 2004, 47 : A329 - A329
[5] Insulin detemir is associated with lower risk of hypoglycemia compared to NPH insulin in people with type 1 diabetes
Kolendorf, K
Pavlic-Renar, I
San-Teusanio, F
Philotheou, A
Gall, MA
Heller, S
DIABETES, 2004, 53 : A130 - A131
[6] No correlation between weight gain and number of hypoglycemic events in patients with type 2 diabetes treated with insulin detemir as compared to NPH insulin
Davies, Melanie
Derezinski, Tadeusz
Kim, Hansoo
Clauson, Per
DIABETES, 2006, 55 : A466 - A466
[7] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
Russel-Jones, D
Bolinder, J
Simpson, R
Stades, A
Stender, A
Hylleberg, B
Draeger, E
DIABETES, 2003, 52 : A132 - A132
[8] Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes
Kolendorf, K.
Ross, G. P.
Pavlic-Renar, I.
Perriello, G.
Philotheou, A.
Jendle, J.
Gall, M-A.
Heller, S. R.
DIABETIC MEDICINE, 2006, 23 (07) : 729 - 735
[9] Insulin detemir is associated with more predictable glycemic control and lower risk of hypoglycemia compared to NPH insulin in subjects with type 1 diabetes
Vague, P
Selam, JL
Skeie, S
De Leeuw, I
Willem, J
Elte, F
Haahr, H
Kristensen, A
Draeger, E
DIABETES, 2002, 51 : A116 - A117
[10] Insulin detemir reduces the risk of hypoglycaemia at all levels of HbA1c compared to NPH insulin in the context of basal-bolus therapy for type 1 diabetes
Jones, DR
Kim, H
Heller, S
Clauson, P
DIABETOLOGIA, 2005, 48 : A92 - A93

← 1 2 3 4 5 →